Codexis Awarded ARPA-E Grant for Carbon Capture Clean Air Technology


<p>REDWOOD CITY, Calif., <span class="xn-chron">May 3</span> /CNW/ -- Codexis, Inc. (Nasdaq:   CDXS) today announced that the company has been selected to receive up to a <span class="xn-money">$4.7 million</span> grant from the U.S. Department of Energy for development of innovative technology to remove carbon dioxide from coal-fired power plant emissions.  This is the company's first grant under the ARPA-E Recovery Act program.</p>
<p>The grant supports development of biocatalysts for more efficient carbon capture from coal-fired power plants.  Coal-fired power plants are major emitters of carbon dioxide, a significant greenhouse gas believed to contribute to global warming. The technology is based on customized carbonic anhydrase biocatalysts that have the potential to enable cost effective, energy efficient capture of carbon dioxide.  Codexis is developing this technology in collaboration with CO2 Solution Inc. (TSX-V: CST) of <span class="xn-location">Quebec</span> City, <span class="xn-location">Quebec</span>, <span class="xn-location">Canada</span>.</p>
<p>According to the Department of Energy, the award was announced <span class="xn-chron">April 29</span> by Vice <span class="xn-person">President Joseph Biden</span> and Secretary of Energy <span class="xn-person">Steven Chu</span> as part of a <span class="xn-money">$106 million</span> award through the DOE's Advanced Research Projects Agency-Energy (ARPA-E) program.  DOE made the award to projects that "could fundamentally change the way the country uses and produces energy" and "could produce advanced biofuels more efficiently from renewable electricity instead of sunlight; design completely new types of batteries to make electric vehicles more affordable; and remove the carbon pollution from coal-fired power plants in a more cost effective way."</p>
<p>Codexis, Inc. is a leading provider of optimized biocatalysts that make existing industrial processes faster, cleaner and more efficient than current methods and have the potential to make new industrial processes possible at commercial scale.  Codexis has commercialized its biocatalysts in the pharmaceutical industry and is developing biocatalysts for use in producing advanced biofuels under a multi-year research and development collaboration. The company is also using its technology platform to pursue biocatalyst-enabled solutions in other bioindustrial markets, including carbon management, water treatment and chemicals.</p>
<p>Contact: <span class="xn-person">Lyn Christenson</span>, <a href=""></a>, 650-421-8144 or Saskia Sidenfaden, <a href=""></a>, 212-827-3771.</p>


For further information: For further information: Lyn Christenson of Codexis, Inc., +1-650-421-8144,, or Saskia Sidenfaden, +1-212-827-3771,,.for Codexis, Inc. Web Site:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890